Toxins 2015, 7(7), 2435-2453; https://doi.org/10.3390/toxins7072435
Botulinum Toxin as a Pain Killer: Players and Actions in Antinociception
1
Department of Life Science, School of Natural Science, Hanyang University, Seoul 133-791, Korea
2
BK21 PLUS Life Science for BioDefense Research (BDR) Team, Hanyang University, Seoul 133-791, Korea
3
The Research Institute for Natural Science, Hanyang University, Seoul 133-791, Korea
†
These authors contributed equally to this work.
*
Authors to whom correspondence should be addressed.
Academic Editor: Bahman Jabbari
Received: 31 May 2015 / Revised: 19 June 2015 / Accepted: 23 June 2015 / Published: 30 June 2015
(This article belongs to the Collection Botulinum Toxins on Human Pain)
Abstract
Botulinum neurotoxins (BoNTs) have been widely used to treat a variety of clinical ailments associated with pain. The inhibitory action of BoNTs on synaptic vesicle fusion blocks the releases of various pain-modulating neurotransmitters, including glutamate, substance P (SP), and calcitonin gene-related peptide (CGRP), as well as the addition of pain-sensing transmembrane receptors such as transient receptor potential (TRP) to neuronal plasma membrane. In addition, growing evidence suggests that the analgesic and anti-inflammatory effects of BoNTs are mediated through various molecular pathways. Recent studies have revealed that the detailed structural bases of BoNTs interact with their cellular receptors and SNAREs. In this review, we discuss the molecular and cellular mechanisms related to the efficacy of BoNTs in alleviating human pain and insights on engineering the toxins to extend therapeutic interventions related to nociception. View Full-TextKeywords:
botulinum neurotoxin; pain; nociception; neurotransmitter; neuropeptide; TRP
▼
Figures
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).